In this issue:
Long-term survival in nivolumabtreated NSCLC patients
Ensartinib for the treatment of crizotinib-resistant ALK+ NSCLC
Combination of TTFields and chemotherapy in pleural mesothelioma
Quality of life in durvalumab-treated NSCLC patients
Ramucirumab + TKI in EGFR mutated NSCLC patients
IL-10 receptor agonist + PD-1 inhibitor for advanced solid tumours
Phase II data for apatinib-treated advanced SCLC patients
Bevacizumab + TKI therapy for EGFRmutant NSCLC patients with brain metastases
Long-term outcomes in durvalumabtreated NSCLC patients
Confocal laser endomicroscopy in the diagnosis of mesothelioma
Please login below to download this issue (PDF)